Journal of Antivirals & Antiretrovirals
Open Access
ISSN: 1948-5964
+44 1300 500008
ISSN: 1948-5964
+44 1300 500008
Rodney Colina
Scientific Tracks Abstracts: JAA
Translation initiation is a highly regulated process. In eukaryotes the ribosome recruitment is facilitated by the 5´-cap structure (m7GpppN, where N is any nucleotide) present on all nuclear transcribed mRNAs (1). Th e cap structure is recognized by eukaryotic initiation factor 4F (eIF4F). It is well established that, activated downstream of PI3´K and Akt, mTOR modulates signal transduction pathways that play central roles in the initiation of mRNA translation. mTOR regulates protein synthesis through the phosphorylation and inactivation of the repressor eukaryotic initiation factor 4E-binding protein (4E-BP1/2), and through the phosphorylation and activation of S6 kinase (S6K1) (2). mTOR exists in two complexes: mTOR complex 1 (mTORC1), which is sensitive to the drug rapamycin and regulates mRNA translation, and mTORC2 which is rapamycin insensitive (3). Type I interferon (IFN) is an essential component of the antiviral response and its production is controlled by transcription. Nevertheless, during last years it has being described that translational control is critical for induction of type-I IFN production (4). Several groups showed that mTORC1 stimulates type I IFN production trough phosphorylation of its target proteins 4E-BPs and S6K1/2 (5). Furthermore, the role of mTORC1 signaling pathway in innate immunity response was demonstrated using a inhibitor ?rapamycin? that block mTORC1 and as consequence suppresses type I IFN production in plasmacytoid dendritic cells (pDCs)(6). Previously we describe that the lack of the translational repressors 4E-BP1/2 leads to enhanced type I IFN production, because the interferon regulatory factor 7 (IRF7) messenger RNA is more effi ciently translated, resulting in elevated expression of IRF7 (7). In this work we demonstrate that in mouse embryonic fi broblasts cells and also in the mice lacking the translational repressors 4E-BP1 and 4E-BP2, the replication of vesicular stomatitis virus is suppressed almost totally. Th ese fi ndings showed the role of 4E-BPs as negative regulators of type-I IFN production, via translational repression of Irf7 mRNA. In addition, genetic deletion of the mTOR downstream target S6K1/2 leads to impaired type I IFN response. In this work it was showed that mouse embryonic fi broblasts and mice lacking S6K1 and S6K2 are more susceptible to vesicular stomatitis virus (VSV) infection than their WT counterparts as a result of an impaired type I IFN response (8). Finally, recently we showed that Leishmania down-regulates macrophage protein synthesis and aff ects its polysome distribution. Th e molecular mechanism involves the parasite protease GP63, which cleaves and disrupts the formation of mTORC1 and leads to the activation of the translational repressors 4E-BP1 and 2. Rapamycin treatment, which activates 4E-BPs, results in a dramatic increase in parasite survival. In contrast, a reduced parasite load is observed in 4EBP1/ 2 double knockout (DKO) macrophages. Remarkably, 4E-BP1/2 DKO mice are signifi cantly less susceptible to cutaneous leishmaniasis. Th is phenotype was explained by enhanced type-I IFN immune response (9). All of these research were done in a mice model, now we are working with diff erents human cell lines, in order to corroborate these fi ndings in our specie. In conclusion, these studies demonstrate the central role that ?translational control? plays in modulating the innate immune response through the IFN production.